Halaven (eribulin) demonstrates overall survival benefit in rare soft tissue sarcoma
Phase III data show Halaven® (eribulin) offers a significant overall survival benefit in people with advanced leiomyosarcoma (LMS) and adipocytic sarcoma (liposarcomas)1 compared to dacarbazine...
More... |
All times are GMT -7. The time now is 07:02 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021